指南与共识泌尿生殖技术与安全MRPETCT

影像、肿瘤与放射学组织关于前列腺癌管理建议:当前推荐意见总结

Recommendations from Imaging, Oncology, and Radiology Organizations to Guide Management in Prostate Cancer: Summary of Current Recommendations.
指南 / 共识 · Radiol Imaging Cancer · 2025-01-01

本综述汇总美国放射学会、美国泌尿外科学会、欧洲泌尿外科学会、美国临床肿瘤学会及国家综合癌症网络等机构的前列腺癌影像指南,比较各机构方法学(专家小组、证据分级、修订周期)及不同疾病状态下的影像推荐,指出多参数MRI在诊断及主动监测前分期中的重要性已获共识,PSMA PET/CT在转移及复发疾病中作用显现,但在不利中危前列腺癌转移检测及PSMA PET/CT当前应用上存在分歧。

要点

  • 多参数MRI用于前列腺癌诊断及主动监测前分期的重要性在各指南中已获共识。
  • PSMA PET/CT在转移性和复发性前列腺癌中的作用正在显现。
  • 不利中危前列腺癌转移检测的影像推荐及各机构对PSMA PET/CT当前应用的看法存在差异。

核心结论

  • 各指南对多参数MRI在前列腺癌诊断及主动监测前分期中的重要性存在共识,PSMA PET/CT在转移和复发疾病中作用显现,但在不利中危前列腺癌转移检测及PSMA PET/CT当前应用上存在分歧,且各指南小组的放射学专业知识存在差异、影像推荐仍不一致。

研究设计与样本

  • 综述,汇总美国放射学会、美国泌尿外科学会、欧洲泌尿外科学会、美国临床肿瘤学会及国家综合癌症网络等主要机构的前列腺癌影像指南,并概述各机构在专家小组构成、指南制定、证据分级及修订周期方面的方法。

局限性

  • 各指南小组的放射学专业知识存在差异。
  • 前列腺癌影像推荐仍存在不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Prostate cancer is the second most common malignancy among male individuals in the United States and requires careful imaging approaches because of its varied presentations. This review examines prostate cancer imaging guidelines from leading organizations, including the American College of Radiology, American Urological Association, European Association of Urology, American Society of Clinical Oncology, and National Comprehensive Cancer Network, and serves as a reference highlighting commonalities and divergences in current imaging recommendations across prostate cancer states. We outline these organizations and their methods, focusing on their approaches to panel expertise, guideline development, evidence grading, and revision schedules. We then compare and contrast the role of various imaging modalities across states of prostate cancer management in the following categories: clinically suspected prostate cancer, clinically established prostate cancer: active surveillance or staging, monitoring metastatic disease, and posttreatment follow-up: recurrent or residual disease. Overall, there is consensus on the importance of multiparametric MRI in diagnosis and staging prior to active surveillance and the emerging role of prostate-specific membrane antigen (PSMA) PET/CT in metastatic and recurrent disease. However, there is disparity in imaging recommendations for detecting metastases in unfavorable intermediate-risk prostate cancer and views on current applications of PSMA PET/CT. Ultimately, variations in radiologic expertise exist among guideline panels, and there continue to be inconsistencies in imaging recommendations in prostate cancer. Keywords: Prostate, Genital/Reproductive, Oncology Supplemental material is available for this article. © RSNA, 2025.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Mew A, Chau E, Bera K, et al. Recommendations from Imaging, Oncology, and Radiology Organizations to Guide Management in Prostate Cancer: Summary of Current Recommendations. Radiol Imaging Cancer. 2025. PMID: 39792015. doi:10.1148/rycan.240091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。